Financial Reports Latest Updates Industry Maps Economic Calendar

KYNTRA BIO, INC. (KYNB) Annual Reports

Q: Where can I read KYNTRA BIO, INC. (KYNB) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

KYNTRA BIO, INC. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 921299 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$-1.5M	$1.3M	-209.3%
Operating income	$-17.6M	$-12.1M	-45.8%
Net income	$12.0M	$-7.6M	+257.5%
EPS (diluted)	$2.96	$-1.88	+257.4%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue -1.47 mn Net income 12.0 mn

Show table：Income statement

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	102	17.9	90.0	13.7	16.1	16.3	121	19.5	24.4	28.3	89.3	30.1	35.5	26.9	30.3	40.5	30.7	31.9	44.0	29.0	108	23.9	192	33.2	7.97	24.4	42.9	44.0	65.0	38.4	24.4	156	16.5	60.8	29.8	15.7	34.4	36.2	44.3	40.1	27.1	55.9	50.6	46.3	-123	2.74	1.35	1.08	1.28	3.74	-1.47
Operating income	-7.95	-14.2	49.2	-37.1	-48.0	-44.7	59.3	-43.8	-48.5	-26.8	26.5	-22.1	-31.3	-31.4	-31.4	-36.0	-23.8	-40.6	-23.2	-42.8	19.9	-48.8	113	-52.9	-100	-81.1	-85.1	32.3	-58.0	-70.4	-134	51.0	-135	-63.0	-78.2	-93.7	-66.2	-76.1	-88.0	-63.5	-54.2	-31.1	-10.9	-16.8	-91.7	-14.9	-12.1	-5.41	-13.5	-13.8	-17.6
Net income	-14.9	-16.2	46.8	-39.5	-50.6	-46.4	57.1	-45.1	-51.4	-27.8	24.3	-24.1	-34.0	-33.2	-33.2	-37.7	-22.1	-41.4	-23.4	-42.6	20.9	-45.4	116	-49.4	-98.1	-78.3	-85.3	33.0	-58.6	-71.8	-134	49.8	-134	-63.2	-72.6	-91.7	-66.2	-76.7	-87.7	-63.6	-56.2	-32.9	-15.5	-17.1	18.0	4.64	-7.60	201	-14.2	-15.2	12.0

Balance sheet

Quarterly · In mn (USD)

Total assets 101 mn Total liabilities 109 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	198	155	264	233	201	184	252	253	267	257	371	741	749	717	720	679	690	579	806	786	702	736	727	737	755	622	564	573	474	524	521	474	493	431	411	364	332	278	209	245	197	149	162	133	99.1	101	96.8
Total assets	—	—	—	—	484	436	541	499	471	443	499	486	470	442	543	895	899	868	870	856	881	812	915	894	857	824	808	812	827	787	809	851	774	746	687	609	610	539	515	460	424	366	293	264	215	165	178	137	120	110	101
Current liabilities	—	—	—	—	62.8	54.0	63.5	59.0	67.2	58.3	66.4	61.7	65.1	60.1	59.8	68.5	77.3	83.3	90.6	100	89.0	93.9	82.8	87.3	103	66.1	77.6	118	163	167	233	209	226	255	240	252	274	255	194	209	218	197	149	191	133	73.4	156	36.0	29.2	28.1	36.0
Total liabilities	—	—	—	—	243	232	269	263	274	266	287	289	294	291	293	304	316	349	355	365	352	304	267	280	322	347	393	341	385	397	529	505	545	568	563	563	612	567	575	576	586	552	484	466	398	340	359	120	115	119	109
Equity	-60.8	—	—	—	221	185	254	217	178	157	193	178	156	132	230	572	563	500	496	471	509	489	629	594	516	458	396	452	422	371	261	326	209	158	104	26.3	-21.4	-48.9	-102	-157	-204	-228	-232	-244	-226	-217	-223	-17.0	-30.0	-43.8	-30.1

Cash flow

Quarterly · In mn (USD)

Operating -3.99 mn Investing 17.7 mn Financing 0 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	25.9	-15.5	92.8	-31.1	-23.8	-42.2	101	-38.1	-39.3	-17.3	44.7	-1.77	-18.6	-27.1	-19.8	-18.4	-1.19	-32.0	-35.0	8.25	-17.5	22.5	-28.6	-27.5	-45.0	-59.5	150	-1.35	-7.23	-45.0	-26.5	44.3	-55.0	-8.48	-33.1	-51.9	-52.5	-102	-111	-84.5	-18.3	-59.3	-39.9	-8.38	-30.5	2.72	12.7	-1.85	-18.3	-13.9	-3.99
Investing	10.8	12.2	17.4	3.41	-140	4.55	1.49	8.26	-20.2	5.06	2.09	8.59	-9.11	23.4	16.9	9.54	20.0	15.3	14.6	-89.2	-463	-26.5	18.8	153	-25.0	56.0	154	98.9	144	-197	-57.5	-122	-50.6	25.9	17.3	44.8	1.09	103	-14.3	54.2	10.2	51.3	72.2	0.76	1.72	-0.02	-0.01	87.2	-51.7	3.02	17.7
Financing	0.68	-0.06	-0.47	-1.03	176	0.62	4.79	2.81	4.13	-0.15	2.65	1.09	3.15	0.57	122	370	3.41	2.05	5.09	3.92	2.82	-3.53	2.75	-3.24	-0.28	-1.19	4.65	4.22	5.66	-2.08	2.38	-0.83	-0.03	-2.89	2.09	-1.09	48.7	31.5	91.5	-0.02	-0.25	-0.16	0.03	-0.13	0.01	-0.09	-0.01	-85.9	-0.01	-0.01	0
Cash at period end	76.3	73.0	183	154	165	128	237	209	153	141	190	198	174	171	290	651	674	659	644	567	89.3	81.7	74.6	197	126	122	429	532	678	434	353	275	171	186	168	156	156	189	153	121	114	106	141	131	50.5	33.6	23.4	118	47.9	37.0	50.6

Profitability

Quarterly · %

Operating margin -369.7% Net margin -406.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	-7.8%	-79.5%	54.7%	-271.5%	-297.9%	-274.4%	49.2%	-224.0%	-198.2%	-94.7%	29.7%	-73.4%	-88.0%	-116.7%	-103.8%	-88.8%	-77.5%	-127.2%	-52.9%	-147.3%	18.4%	-204.7%	58.9%	-159.3%	-1259.5%	-332.3%	-198.5%	73.4%	-89.2%	-183.3%	-549.3%	32.7%	-817.5%	-103.6%	-262.4%	-595.2%	-192.5%	-210.4%	-198.7%	-158.2%	-199.7%	-55.6%	-21.6%	-36.2%	—	-544.7%	-894.1%	-502.9%	-1058.1%	-369.7%	—
Net margin	-14.6%	-90.8%	52.1%	-289.4%	-313.9%	-284.5%	47.3%	-230.8%	-210.2%	-98.4%	27.2%	-80.2%	-95.7%	-123.3%	-109.6%	-93.1%	-72.0%	-129.7%	-53.3%	-146.6%	19.4%	-190.3%	60.6%	-149.0%	-1230.5%	-321.1%	-198.9%	75.0%	-90.2%	-186.7%	-549.9%	31.9%	-810.5%	-103.9%	-243.7%	-582.5%	-192.6%	-212.1%	-197.8%	-158.5%	-207.2%	-58.9%	-30.7%	-36.9%	—	169.4%	-564.0%	18646.5%	-1113.5%	-406.6%	—

Returns & leverage

Quarterly · %

ROE -42790.2% ROA 131.3% Debt ratio 108.1%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	-74.1%	-48.5%	-31.3%	-39.1%	-43.0%	-39.4%	-44.8%	-40.0%	-37.0%	-46.4%	-58.8%	-36.8%	-35.1%	-42.6%	-34.4%	-24.8%	-16.1%	-18.3%	8.7%	7.9%	-15.0%	-23.2%	-60.7%	-43.7%	-40.4%	-44.1%	-70.5%	-55.2%	-91.9%	-106.4%	-120.8%	-205.4%	-312.9%	-562.6%	-42790.2%	—	—	—	—	—	—	—	—	—	—	—	—
ROA	—	—	—	—	-12.3%	-20.6%	-14.7%	-17.0%	-18.0%	-15.3%	-19.2%	-16.0%	-13.1%	-15.2%	-23.9%	-20.0%	-18.4%	-20.5%	-17.6%	-14.8%	-9.7%	-10.8%	5.5%	4.8%	-8.9%	-13.4%	-36.1%	-26.8%	-22.5%	-22.7%	-28.6%	-25.8%	-36.2%	-36.7%	-29.4%	-49.5%	-42.4%	-47.8%	-53.6%	-55.0%	-55.0%	-53.2%	-41.6%	-33.6%	-14.9%	-3.8%	-0.9%	107.4%	109.8%	119.1%	131.3%
Debt ratio	—	—	—	—	50.2%	53.2%	49.6%	52.6%	58.2%	60.2%	57.5%	59.4%	62.7%	65.8%	54.0%	34.0%	35.2%	40.2%	40.8%	42.7%	40.0%	37.4%	29.1%	31.4%	37.5%	42.1%	48.6%	42.0%	46.6%	50.4%	65.4%	59.4%	70.4%	76.1%	82.0%	92.4%	100.2%	105.4%	111.7%	125.0%	138.3%	150.9%	164.9%	176.3%	185.6%	205.9%	201.7%	87.2%	96.3%	108.5%	108.1%

EPS

Quarterly · US$

EPS US$2.96

Show table：EPS

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	0.58	—	—	—	0.83	—	—	—	0.35	—	—	—	-0.48	—	—	—	-0.28	-0.50	—	—	1.26	-0.57	—	—	-0.95	0.35	-0.65	—	-1.45	0.54	-1.45	-0.68	-0.78	-0.98	-0.71	-0.81	-0.90	-0.65	-0.57	-0.33	-0.16	-0.17	0.18	0.05	-1.88	49.61	-3.53	-3.76	2.96

Revenue & profit

Year-to-date · In mn (USD)

Revenue 2.26 mn Net income -3.22 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 101 mn Total liabilities 109 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -17.9 mn Investing 20.7 mn Financing -0.01 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -1386.6% Net margin -142.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -42790.2% ROA 131.3% Debt ratio 108.1%

EPS

Year-to-date · US$

EPS US$-0.80

Revenue & profit

Annual · In mn (USD)

Revenue 6.44 mn Net income 183 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	138	181	183	128	213	257	176	235	141	148	29.6	6.44
Operating income	-50.1	-77.6	-53.6	-123	-86.7	-89.3	-192	-289	-301	-282	-150	-45.9
Net income	-59.5	-85.8	-61.7	-126	-86.4	-77.0	-189	-290	-294	-284	-47.6	183

Balance sheet

Annual · In mn (USD)

Total assets 120 mn Total liabilities 115 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	198	201	267	749	690	702	755	474	493	332	197	99.1
Total assets	484	471	470	899	881	857	827	774	610	424	215	120
Current liabilities	62.8	67.2	65.1	77.3	89.0	103	163	226	274	218	133	29.2
Total liabilities	243	274	294	316	352	322	385	545	612	586	398	115
Equity	221	178	156	563	509	516	422	209	-21.4	-204	-226	-30.0

Cash flow

Annual · In mn (USD)

Operating -4.77 mn Investing 35.4 mn Financing -86.0 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	22.4	-18.6	7.11	-66.5	-76.1	-78.7	81.6	-82.2	-146	-315	-138	-4.77
Investing	-107	-5.87	6.62	69.9	-522	120	452	-427	89.1	154	126	35.4
Financing	174	12.3	6.74	496	13.9	-4.30	13.3	-0.56	46.8	123	-0.25	-86.0
Cash at period end	165	153	174	674	89.3	126	678	171	156	114	50.5	47.9

Profitability

Annual · %

Operating margin -712.7% Net margin 2848.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	-36.4%	-42.9%	-29.3%	-95.5%	-40.7%	-34.8%	-108.8%	-122.6%	-213.9%	-190.7%	-507.8%	-712.7%
Net margin	-43.2%	-47.4%	-33.7%	-98.3%	-40.6%	-30.0%	-107.4%	-123.3%	-208.7%	-192.4%	-160.6%	2848.6%

Returns & leverage

Annual · %

ROE -312.9% ROA 109.8% Debt ratio 96.3%

Show table：Returns & leverage

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-26.9%	-43.0%	-37.0%	-35.1%	-16.1%	-15.0%	-40.4%	-91.9%	-312.9%	—	—	—
ROA	-12.3%	-18.0%	-13.1%	-18.4%	-9.7%	-8.9%	-22.5%	-36.2%	-42.4%	-55.0%	-14.9%	109.8%
Debt ratio	50.2%	58.2%	62.7%	35.2%	40.0%	37.5%	46.6%	70.4%	100.2%	138.3%	185.6%	96.3%

EPS

Annual · US$

EPS US$44.25

Show table：EPS

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	—	—	—	—	-3.15	-2.93	-0.48	44.25

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read KYNTRA BIO, INC. (KYNB) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.